相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients
Dickran Kazandjian et al.
BLOOD CANCER JOURNAL (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: a prospective analysis in three large cohorts
Catherine R. Marinac et al.
BRITISH JOURNAL OF CANCER (2018)
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials
Sikander Ailawadhi et al.
BLOOD CANCER JOURNAL (2018)
Global Burden of Multiple Myeloma ASystematic Analysis for the Global Burden of Disease Study 2016
Andrew J. Cowan et al.
JAMA ONCOLOGY (2018)
Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry
Linda B. Baughn et al.
BLOOD CANCER JOURNAL (2018)
Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications
E. Dianne Pulte et al.
BLOOD ADVANCES (2018)
Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study
Su-Hsin Chang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Genomic complexity of multiple myeloma and its clinical implications
Salomon Manier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study
Su-Hsin Chang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12 372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey
O. Landgren et al.
BLOOD CANCER JOURNAL (2017)
Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet?
Sikander Ailawadhi et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2017)
Comprehensive molecular profiling of 718 Multiple Myelomas reveals significant differences in mutation frequencies between African and European descent cases
Zarko Manojlovic et al.
PLOS GENETICS (2017)
Socioeconomic and Racial/Ethnic Disparities in Cancer Mortality, Incidence, and Survival in the United States, 1950-2014: Over Six Decades of Changing Patterns and Widening Inequalities
Gopal K. Singh et al.
JOURNAL OF ENVIRONMENTAL AND PUBLIC HEALTH (2017)
Medical Mistrust and Colorectal Cancer Screening Among African Americans
Leslie B. Adams et al.
JOURNAL OF COMMUNITY HEALTH (2017)
Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC)
Brenda M. Birmann et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Racial disparities in treatment use for multiple myeloma
Mark A. Fiala et al.
CANCER (2017)
Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States
Luciano J. Costa et al.
BLOOD ADVANCES (2017)
Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features
MaryAnn E. VanValkenburg et al.
CANCER CAUSES & CONTROL (2016)
Obesity Epidemiology Worldwide
Cassandra Arroyo-Johnson et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2016)
Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma
Luciano J. Costa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Determining the Clinical Significance of Monoclonal Gammopathy of Undetermined Significance: A SEER-Medicare Population Analysis
Ronald S. Go et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium
Rafael Rios et al.
ENDOCRINE-RELATED CANCER (2015)
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study
A. J. Greenberg et al.
BLOOD CANCER JOURNAL (2015)
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma
Elin Edda Sigurdardottir et al.
JAMA ONCOLOGY (2015)
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
Neha Korde et al.
JAMA ONCOLOGY (2015)
Disparities in Black and White Patients With Multiple Myeloma Referred for Autologous Hematopoietic Transplantation: A Single Center Study
Vishal Bhatnagar et al.
CANCER (2015)
IMWG consensus on risk stratification in multiple myeloma
W. J. Chng et al.
LEUKEMIA (2014)
Recent improvement in survival of patients with multiple myeloma: variation by ethnicity
Dianne Pulte et al.
LEUKEMIA & LYMPHOMA (2014)
Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach
Angela Baker et al.
BLOOD (2013)
Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
Maria-Victoria Mateos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study
Terry Golombick et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients
Brendan M. Weiss et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies
Neha Korde et al.
BLOOD (2011)
Race, socioeconomic status, and health: Complexities, ongoing challenges, and research opportunities
David R. Williams et al.
BIOLOGY OF DISADVANTAGE: SOCIOECONOMIC STATUS AND HEALTH (2010)
Race and Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Parameswaran N. Hari et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women
Ola Landgren et al.
BLOOD (2010)
Racial disparities in incidence and outcome in multiple myeloma: a population-based study
Adam J. Waxman et al.
BLOOD (2010)
More than Tuskegee: Understanding Mistrust about Research Participation
Darcell P. Scharff et al.
JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED (2010)
Familial myeloma and monoclonal gammopathy: A report of eight African American families
Maneesh Jain et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
A monoclonal gammopathy precedes multiple myeloma in most patients
Brendan M. Weiss et al.
BLOOD (2009)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
Risk of plasma cell and lymphoproliferative disorders among 14 621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden
Ola Landgren et al.
BLOOD (2009)
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance
Celine M. Vachon et al.
BLOOD (2009)
Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group
Kathy S. Albain et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis
O. Landgren et al.
LEUKEMIA (2009)
Familial myeloma
Henry T. Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States)
Mulugeta Gebregziabher et al.
CANCER CAUSES & CONTROL (2006)
Prevalence of monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States
O Landgren et al.
BLOOD (2006)
Racial disparities in hypertension prevalence, awareness, and management
RP Hertz et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
SV Rajkumar et al.
BLOOD (2005)
Clinical and biologic implications of recurrent genomic aberrations in myeloma
R Fonseca et al.
BLOOD (2003)
Myeloma and race: A review of the literature
M Benjamin et al.
CANCER AND METASTASIS REVIEWS (2003)
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy
P Moreau et al.
BLOOD (2002)
Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients
R Fonseca et al.
BLOOD (2002)
A long-term study of prognosis in monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Socioeconomic status and multiple myeloma among US Blacks and Whites
D Baris et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2000)
分享论文
